Charles University in Prague, Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Technology Student: Natália Pribylincová Consultant: Doc. RNDr. Milan Řehula, CSc. Effect of ascorbic acid on the parameters of compression equation Many mathematical models describing the compressing process are widely used in the development of new medicinal products in form of tablets. This process can be evaluated by means of compaction equations or throughout the viscoelastic properties. Compaction equation expresses dependency on height, volume or density of the used material which is being compressed by the applied compacting pressure. Based on the gained parameters, it is possible to describe specifically various stages of the compaction process, to determine characteristic properties of the studied material and accordingly to examine its mechanism. This thesis deals with the impact of the ascorbic acid on the parameters of compaction equation. The paperwork evaluates a mixture consisting of ascorbic acid (AA) and microcrystalline cellulose (MCC) in the ratio of MCC : AA 100:0, 75:25, 50:50, 25:75, 0:100. . The mostly used compression equations are described in the theoretic part. The three - exponential equation by Řehula created at the Department of Pharmaceutical Technology at Charles...

Charles University in Prague, Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Technology Student: Tisoňová Zuzana Consultant: Doc. RNDr. Milan Řehula, CSc. Compacting process is mathematically expressed by compression equations. It is characterized by various parameters of equations. The equation expresses the dependence of the volume, density and height on compacting pressure. In this paperwork, the parameters of compacting equation are evaluated and the pre-loading phase, the phase of elastic deformation and the phase of plastic deformation are studied. This thesis deals with impact of ibuprofen on the parameters of compaction equation. Five mixtures which included microcrystalline celulose and ibuprofen in different ratio 100:0, 75:25, 50:50, 25:75 and 0:100 were studied. Results were based on the three-exponential equation. They were evaluated thanks to box plots. From the results obtained, it is obvious that with decreasing amount of microcrystalline cellulose, the parameter a1 has increased and the parameter E1 also slightly has increased. The composition of the used material didn't have any huge influence on parameters 1/t1 and pH1. During the phase of elastic deformation, the parameters a2 and E2 with decreasing amount of ibuprofen have decreased. On the other hand, the...

Charles University in Prague, Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Technology Student: Jakub Šmíd Consultant: Doc. RNDr. Milan Řehula, CSc. Effect of acetylsalicylic acid on the parameters of compression equation Compacting process can be expressed mathematically by compression equations. It is characterized by various parameters. The compression equation expresses the dependence of the volume, density and height on compacting pressure. This paper evaluates the parameters of the compaction equation and study pre-loading phase, the phase of elastic deformation and the phase of plastic deformation. This thesis examines effect of acetylsalicylic acid on the parameters of compaction equation. Tablets were compressed from five mixtures. Mixtures contained acetylsalicylic acid and microcrystalline cellulose in different ratios 0:100, 25:75, 50:50, 75:25 and 0:100. The results were obtained using the three-exponential equation. Evaluation was carried out by using box plots.

Charles University in Prague, Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical technology Supervisor: Doc. RNDr. Milan Řehula, CSc. Title of Dissertation: Validation of a new method for the evaluation of stress relaxation of tablets Keywords: tablets, stress relaxation test, elastic and plastic deformation The theoretical part of this thesis deals with the elastic relaxation of tablets. It describes various methods used in the evaluation of elastic recovery of tablets. The present work explores the factors affecting the elastic relaxation of tablets. The experimental part is focused on the stress relaxation test. Until present only one delay was studied. This work studies the stress relaxation after relieving tablet. The parameters A2, T2 and P2 were reviewed. The relationship between the parameters P2 and compression force relief were studied. For experiments microcrystalline cellulose Avicel PH 102 (MCC) was used. Tablets were compressed in a device used for testing the strength of the material in pressure and tension T1-FRO 50. For the determination of the stress relaxation test, the tablets were compressed with 180 sec first delay. The second delay was always 60 sec but it was measured from certain decrease of pressure (7 kN, 6 kN, 5 kN, 4 kN, 3 kN, 2 kN, 1 kN and 0.1 kN). To...

Charles University in Prague, Faculty of Pharmacy in Hradci Králové Department of: Pharmaceutical technology Consultant: PharmDr. Pavel Ondrejček, Ph.D. Student: Natálie Havlíková Title of Thesis: The effect of particle size on lactose compressibility It is known that the particle size of the compressed material plays an important role in the manufacture of tablets. It affects the properties of intermediate and final products. In this thesis the properties of tablets made of two lactose types, which were used as model fillers, were studied. These were Tablettose® 80 and Lactopress® Anhydrous. In both lactose types, five sieved size fractions of the particle size ranging from 9 to 346µm and their original unsieved mixture were used. The compaction forces ranging from 2 to 10kN were used for tablet preparation. Magnesium stearate was used for external lubrication. The evaluation of the prepared tablets was done mainly by using the pharmacopoeial methods. The evaluated parameters were friability, disintegration time and hardness. Furthermore, the elasticity of the tablets and the evaluation using the force-displacement method parameters were assessed. From the results of this work, it is not possible to unambiguously determine the advantage of one particular fraction size in the comparison to the...

Foram produzidos comprimidos de liberação prolongada de teofilina baseados em matrizes hidrofílicas de misturas de hidroxipropilmetilcelulose e etilcelulose e polietilenoglicol. O planejamento estatístico de mistura Design Expert® foi empregado na seleção da composição do sistema de controle da liberação e, numa segunda fase, para otimização das formulações de comprimidos. Foram produzidas 26 formulações por compressão direta e as características físico-químicas dos comprimidos como peso médio, friabilidade, dureza e teor de fármaco foram determinadas. A porcentagem de teofilina liberada foi avaliada conforme o método da Farmacopéia Americana 30 ed. (2007), para cápsulas de liberação prolongada (Teste 10 - pá), por um período de 8 horas. Conforme as farmacopéicas os comprimidos produzidos apresentaram características físico-químicas de acordo com as especificações, com exceção das formulações 2 e 3, para o teste de friabilidade, cujos valores foram superiores. Entretanto, quanto ao ensaio de dissolução, a formulação 13, constituída por 30% de etilcelulose, atendeu aos valores preconizados para liberação prolongada de teofilina. As respostas obtidas dos experimentos foram introduzidas no programa Design Expert® que gerou superfícies de respostas nas quais foi possível avaliar a influência da composição nos parâmetros friabilidade e porcentagem de teofilina liberada na dissolução. Dessa forma, foi possível obter 3 formulações com etilcelulose (13,50% a 15,90%), metilcelulose tipo E4MCR (6,90% a 8,10%) e metilcelulose tipo K4MPRCR (0,30% a 0,60%), com as características desejadas empregando o planejamento estatístico de mistura, com o número mínimo de experimentos sem a necessidade de estudar todas as possíveis combinações experimentais, abreviando o trabalho com ganho de tempo. Os resultados encontrados para friabilidade e dissolução nas formulações otimizadas foram próximos dos previstos pela análise de regressão e dentro dos valores especificados na Farmacopéia Americana 30 ed. 2007. / Controlled release dosage forms of theophylline were prepared with hidrophyllic matrix using polymers as hydroxy-methyl-cellulose, hydroxy-ethyl-cellulose and polyethylenglycol. The program Design Expert® was used to select polymers composition and at the second moment, to optimized tablets formulations. It was obtained 26 formulations by direct compression that physical-chemical characteristics of tablets as weight deviation, friability, hardness and drug dosage were performed. Dissolution rate of these tablets were controlled by United States Pharmacopeia 30 ed. Test for theophylline extended-release capsules (test 10 - paddle) corresponding to 8 hours of experiment. The evaluation indicates that tablets produced were in accordance with Brazilian Pharmacopoeia 4 ed., and United States Pharmacopoeia 30 ed., except for formulations 2 and 3 that the values for friability were low. And about dissolution rate of these tablets only formulation 13 applied to preconized value for dissolution method for theophylline extendedrelease capsules. Design Expert® was fed with the results obtained from experiments that showed surface result after that it were possible to analyze the influence of the composition of components on the friability and dissolution rate of theophylline parameters. Considering the specifications, 3 formulations were obtained and were analyzed. The results obtained were close to results predicted for regression analysis and in accordance with Brazilian Pharmacopoeia 4 ed., and United States Pharmacopoeia 30 ed. The proposed experimental Design Expert® program strategy should allow a rapid evaluation and identification of the parameters important in determining the drug release rate from matrix tablets, providing a powerful support for their rational selection during preformulation studies and thus shortening the time necessary for the development of effective dosage forms with the desired drug release behavior.

O tratamento farmacológico de patologias bucais é conduzido, geralmente, por via de adminis-tração local. No entanto, devido ao pouco tempo de permanência do fármaco no local de ação, esse tratamento pode ser bastante comprometido. Assim, este trabalho teve por objetivo o de-senvolvimento de formas farmacêuticas que proporcionem a liberação local de triancinolona na cavidade oral. Foram produzidos filmes e comprimidos mucoadesivos a partir de polímeros naturais como gelana e pectina. Os filmes bucais foram preparados por meio de evaporação do solvente (solvent casting) utilizando diferentes quantidades de polímeros. As matérias-primas e os filmes foram caracterizados fisico quimicamente utilizando espectroscopia vibracional (in-fravermelho com transformada de Fourier e Raman) e difração de raios X. As propiedades físicas e mecânicas dos filmes também foram avaliadas. Além disso, realizou-se os ensaios de mucoadesividade e de dissolução do fármaco. Os comprimidos foram preparados por com-pressão direta usando como base os polímeros naturais. Diferentes parâmetros em relação as misturas e as formulações foram avaliados tais como as propriedades de fluxo dos pós consti-tuintes, peso médio, dureza, friabilidade e desintegração. Em relação aos filmes bucais, estes foram obtidos com sucesso através de um método simples, sem a utilização de agentes reticu-lantes, ácidos ou solventes orgânicos. Todos apresentaram bons resultados nas propriedades avaliadas, no entanto as formulações com quantidades intermediarias de polímeros foram as melhores. Dentre as formulações de comprimidos preparadas, apenas 4 apresentaram boas ca-racterísticas, no entanto, os resultados dos ensaios de dissolução mostraram que estas formula-ções têm capacidade de agir como sistema de liberação controlada de fármacos. / Pharmacological treatment of oral pathologies is usually conducted by local administration. However, due to the short time the drug stays in the site of action, this treatment can be quite compromised. Thus, the objective of this work was to develop pharmaceutical forms that pro-vide the local release of triamcinolone in the oral cavity. Mucoadhesive films and tablets were made from natural polymers such as gellan and pectin. The buccal films were prepared by sol-vent casting using different amounts of polymers. The raw materials and films were characte-rized physically chemically using vibrational spectroscopy (FTIR and Raman) and X-ray diffraction. The physical and mechanical properties of the films were also evaluated. In addi-tion, the mucoadhesive and drug dissolution tests were performed. The tablets were prepared by direct pressing with the natural polymers. Different parameters in relation to mixtures and formulations were evaluated such as the flow properties of the constituent powders, average weight, hardness, friability and disintegration. In relation to oral films, these were successfully obtained by a simple method, without the use of crosslinking agents, acids or organic solvents. All presented good results in the evaluated properties, however the formulations with interme-diate amounts of polymers were the best. Among the tablet formulations prepared, only 4 sho-wed good characteristics, however, the dissolution test results showed that these formulations have the ability to act as a controlled drug delivery system.

A espécie Copaifera langsdorffii pertence à família Leguminosae Juss., sub-família Caesalpinioideae Kunth. No Brasil, espécies de copaifera são amplamente distribuídas nos estados do Amazonas, Pará e Ceará e são mundialmente conhecidas pelo oleorresina que pode ser extraído de forma sustentável do tronco de suas e árvores. Este oleorresina e suas frações voláteis são amplamente estudados. No entanto, poucos estudos se relacionam com a composição química e biológica de outras partes da planta. A atividade antilitiásica do extrato hidroalcoólico das folhas dessa espécie, evidenciada em estudos preliminares pelo grupo de pesquisa e já com pedido de depósito de patente, abriu perspectivas para investigação fitoquímica deste extrato e produção de comprimidos fitoterápicos. Assim, objetivou-se nesse estudo conhecer o perfil químico do extrato, isolar e identificar metabólitos secundários que possam ser utilizados como marcadores da espécie e/ou como padrões cromatográficos, utilizando diferentes modalidades cromatográficas. E ainda, realizar estudos de extração, secagem e de pré-formulação para produção de comprimidos de qualidade contendo teor de extrato em dose adequada à utilização em ensaios clínicos futuros. O perfil químico do extrato e frações obtidas após partição com solventes de polaridade crescente demonstra constituição majoritária de compostos polares. A fracão em AcOEt foi submetida às técnicas de cromatografia em coluna clássica e cromatografia contracorrente (HSCCC) propiciando o isolamento dos compostos 1 (quercetina-3-O--L-raminopiranosídeo) e 2 canferol-3-O--L raminopiranosídeo), após purificação em CLAE preparativa. A fração aquosa foi submetida às técnicas de cromatografia em coluna utilizando gel de sephadex LH-20 e cromatografia contracorrente, propiciando o isolamento dos compostos de 3-10, após purificação em CLAE preparativa. Os compostos 4, 6, 9 e 10 tiveram suas estruturas elucidadas e pertencem à classe dos ácidos galoilquínicos, identificados como ácido 6,4-dimetóxi-3,4-di-O-galoilquínico; ácido 6-metóxi-3,4,5-tri-O-galoilquínico; ácido 4,4-dimetoxi-3,4,5-tri-O-galoilquínico; e ácido 4-metóxil-3-O-galoilquínico, respectivamente. Os estudos de extração levaram à obtenção de três extratos com maior rendimento, sendo o processo de extração simples utilizando-se etanol:água 7:3 (45 mL) com 3 g de droga vegetal, o qual foi de escolha para produção do extrato avaliado no estudo de secagem por spray drying. Os resultados do estudo de secagem não revelaram diferenças significativas entre os experimentos avaliados e as partículas dos extratos secos obtidos não apresentaram boas características de fluxo para compressão direta. A granulação por via úmida do extrato seco contendo 73% de extrato, 25% dos adjuvantes Maltodextrina:Aerosil (1:1) e 2% de polivinil pirolidona, produziu partículas com características e propriedades de fluxo excelentes para a compressão. A compressão dos granulados sem adição de outros excipientes proporcionou comprimidos com dureza elevada e longos tempos de desintegração. No entanto, comprimidos produzidos por mistura prévia com granulado de amido+lactose, apresentaram melhores características físicas, sendo os valores de dureza e friabilidade aceitáveis e tempos de desintegração menores e próximos aos valores recomendados. / Copaifera langsdorffii belongs to Leguminosae Juss. family, sub-family Caesalpinioideae Kunth. In Brazil, Copaifera species are widely spread in Amazonas, Pará and Ceará states and are worldwide known by the oil-resin that can be extracted from its trunk. This oleoresin and its volatile fractions have been studied by many research groups. However, few studies are related to the chemical and biological composition of other plant parts, such as leaves. We have been investigating the antilitiasic activity of the hydroalcoholic extract from C. langsdorffii, and it have risen the in both the phytochemical investigation of the aerial parts and the production of tablets with the obtained extract. Thus, the aim of this study was to evaluate the leaf extract chemical profile, to isolate and identify the secondary metabolites to be used as chromatographic standards, using different chromatographic methods, for the analysis of plant materials, its extracts and products, as well as, to carry out studies of extraction, drying and preformulation to produce tablets containing a suitable dose of the extract for using in future clinical trials. Chemical profile of the extract and its fractions obtained after partition with solvents with increasing polarity revealed that the extract is majorly composed by polar compounds. The ethyl acetate fraction was submitted to classical column chromatography and high speed countercurrent chromatography (HSCCC) techniques, resulting in isolation of compounds 1 (quercetin-3-O--L-rhaminopiranoside) and 2 (kaempferol-3-O--L-rhaminopiranoside, after preparative HPLC purification. The aqueous fraction was submitted to column chromatography techniques using gel filtration (sephadex LH-20) and HSCCC yielding compounds 3 to10, after preparative HPLC purification. Compounds 4, 6, 9 and 10 were identified as galloylquinic acid derivatives 6\',4\'\'-dimethoxy-3,4-di-O-galloylquinic acid; 6\'\'\'-methoxy-3,4,5-tri-O-galloilquinic acid; 4\',4\'\'\'-dimethoxy-3,4,5-tri-O-galloylquinic acid; and 4- methoxy-3-O- galloylquinic acid, respectively. Studies of extraction process furnished three extracts with higher yielding, using a simple extraction process with ethanol: water 7:3 (45 mL) with 3g of plant biomass, which was chosen to obtain the extract for drying studies. Drying results showed no significant differences between the undertaken experiments, and the dried extracts particles did not have good flow properties for direct compression. Wet granulation of dried extract containing 73% of plant extract, 25% of excipients Maltodextrin: Aerosil (1:1) and 2% of polyvinyl pyrrolidone produced particles with excellent flow properties for compression. Granulate compression without adding other excipients furnished tablets with high hardness and long disintegration times. However, granulates prior mixed with amide-lactose produced tablets with better physical properties, such as hardness and friability with acceptable values and adequate disintegration times.

A coerência do processo de fabricação, via granulação úmida, de comprimidos de dipirona sódica (500 mg) foi avaliada empregando ferramentas de qualidade e de estatística. No estudo foi desenvolvida base racional-científica objetivando determinar as etapas críticas do processo por meio da técnica de análise de modo e efeito da falha (FMEA). A análise de risco revelou as potenciais falhas do processo: variação da distribuição granulométrica da mistura final com elevado percentual de pó fino e problemas relativos a fluidez; ensaios de peso, espessura, dureza, friabilidade, tempo de desintegração e dissolução fora de especificação; não-uniformidade do conteúdo de dipirona sódica (OS) na mistura final e durante a compressão e ocorrência de laminação, capeamento, porosidade e aderência dos comprimidos às estações da máquina compressora. Os métodos analíticos relativos à determinação de (OS), empregando metodologia espectrofotométrica e de cromatografia líquida de alta eficiência (CLAE), foram previamente validados. As seguintes características de desempenho, em ambas metodologias analíticas, foram determinadas: especificidade, linearidade com coeficiente de correlação (r) > 0,99, repetibilidade aceitável com desvio padrão relativo (OPR) < 2% e precisão intermediária entre analistas e em dias diferentes. Além disso, a robustez e exatidão com percentual de recuperação entre 99,28% e 100,84% foram comprovadas para o método de CLAE. No que se refere às etapas críticas da validação do processo produtivo, foi elaborado plano de amostragem baseado nos critérios estabelecidos em compêndio oficial (FARMACOPÉIA BRASILEIRA, 1988), Guia da FOA (UNITEO STATES, 2003), duração de cada etapa de fabricação e tipo de equipamento utilizado. Além disso, foi empregada a lista Millitary Standard 105E (TAYLOR, ENTERPRISES, 1989). Os resultados relativos à estabilidade estatística do processo revelaram ausência de causas especiais. Os índices de capacidade Cp e Cpk foram calculados após avaliação da distribuição dos dados empregando teste de Anderson-Darling. Todos os dados apresentaram distribuição normal (p > 0,05), exceto àqueles relativos à uniformidade de conteúdo de OS na etapa de compressão. Esses dados foram tratados utilizando método proposto por Box-Cox (Iambda igual a 5) visando sua normalização. Os índices de capacidade Cp e Cpk. revelaram resultados > 1 e, portanto, permitiram determinar a consistência do processo e baixa probabilidade de falha. / The consistency of the metamizol tablets (500 mg) manufacturing process, via wetting granulation, was evaluated by quality and statistical tools. In this study, rational-scientific base was developed aiming determination of the critical steps of this process, using the Failure Mode and Effects Analysis (FMEA) technique. The risk analysis shows the potential failures of the process: variability of particle size distribution, high percentage of fine powder and flowability problems related to the final mixture; weight, thickness, hardness, friability, disintegration time and dissolution percentage of the tablets out-of-specifications; non-uniformity of the metamizol content in the final mixture and during the tabletting steps; laminating, capping, porosity and sticking of the tablets. The analytical methods performed by spectrophotometric and high performance liquid chromatography (HPLC), in order to assay metamizol, were previously validated. The following parameters were evaluated in both analytical methodologies: specificity, linearity with correlation coefficients more than 0.99, acceptable repeatability with relative standard deviation (RSD) less than 2% and intermediate precision between two different analysts and days. Besides that, the system suitability and accuracy were also proved by HPLC method. The recoveries obtained were between 99.28% and 100.84%. The sampling plan was elaborated according to official compendium (FARMACOPEIA BRASILEIRA, 1988), FOA Guidance (UNITED STATES, 2003), Military Standard 105E (TAYLOR ENTERPRISES, 1989), the duration of each step and the type of equipment used. This plan was just applied for critical steps identified by FMEA tool. The results related to the statistical stability of the process show no special cause. The capability indexes, Cp and Cpk, were calculated after the evaluation of the data distribution using Anderson-Darling test. Ali data showed normal distribution (p > 0.05), except for uniformity of metamizol content of the tablets. This data was treated by a method proposed by Box-Cox (Iambda equal -5.0) aimed at obtaining the normality of the data. The capability indexes, Cp and Cpk, obtained were all > 1. Therefore, this process can be considered consistent and with low probability of failures.

A cefalexina é um antibiótico semi-sintético, derivado das cefalosporinas, que exibe amplo espectro de ação, sendo largamente empregado por via oral. No Brasil é comercializado na forma de comprimido revestido, por cinco laboratórios farmacêuticos diferentes. No presente estudo foram avaliados, do ponto de vista biofarmacotécnico, 2 especialidades farmacêuticas (A e B), sob a forma de comprimidos revestidos, contendo 500 mg de cefalexina, disponíveis no mercado nacional. A análise in vitro foi realizada para dois lotes (1 e 2) de cada produto (A e B), através de ensaios físicos e físico-químicos (peso médio, dureza, umidade, teor de cefalexina, teste e perfil de dissolução), com a finalidade de verificar sua conformidade com especificações estabelecidas pelos compêndios oficiais. Estudos de cinética de dissolução foram empregados para avaliação mais precisa quanto às características biofarmacotécnicas in vitro das respectivas formulações. Os estudos de bioequivalência entre os produtos A e B (lote 2) empregaram delineamento experimental cruzado aleatório, em dois períodos, utilizando-se 24 voluntários. Os parâmetros farmacocinéticos empregados nesta avaliação foram obtidos a partir de dados de excreção urinária da cefalexina, sendo sua concentração na urina determinada por cromatografia líquida de alta eficiência, através de metodologia desenvolvida e validada no presente estudo. A bioequivalência entre os produtos foi determinada a partir da análise estatística (ANOVA) dos seguintes dados: quantidade de cefalexina acumulada excretada na urina (Du acumulado); quantidade total de cefalexina excretada na urina no tempo infinito (Du∞); velocidade máxima de excreção urinária ([Ddu/dt]max). Os resultados das análises físicas e físico-químicas indicaram que ambos os produtos estudados apresentaram-se dentro das especificações farmacopéicas. Na avaliação da bioequivalência entre os mesmos, obtiveram-se intervalos de confiança dentro dos limites estabelecidos internacionalmente (80 a 125%), para todos os parâmetros avaliados, comprovando, desta forma, que os produtos A e B são bioequivalentes e, portanto, intercambiáveis. / Cephalexin is a semi-synthetic cephalosporin-derived antibiotic which has an extensive action spectrum, widely used by oral administration. In Brazil, where it is largely marketed, in a tablet coated way, five differents brands can be found. The goal of this study was to evaluate from the biopharmaceutic point of view two cephalexin 500 mg tablet brands (A and B) availables in brazilian market. In order to check its accordance with official pharmacopeial specifications, two lots (1 and 2) of each brand (A and B) were analysed in vitro through physical and physical-chemical assays in vitro tests (average weight, hardness, wet, cephalexin content, dissolution test). Both formulations were also submitted to dissolution kinetics studies to reach an accurate evaluation of their in vitro biopharmaceutics features. The bioequivalence studies between A and B brands (Iot 2) was based on an open randomized two period cross over design with twenty-four male and female healthy volunteers. Pharmacokinetics parameters used in this evaluation were obtained from cephalexin urinary excretion data; to assess urine cephalexin concentrations a high performance liquid chromatographic assay developed and validated in this study was used. Bioequivalence was confirmed using a multiway ANOVA and when the 90 % confidence interval for accumulated cephalexin amount excreted in urine (Du accumulated); total amount of cephalexín excreted in urine (Du∞ ) and maximum rate of urinary excretion ([dDu/dt]max), fell within the interval 80-125 %.No discrepancies between both cephalexin brands in physical-chemycal tests were found. Confidence intervals for pharmacokinetics parameters were inside the bioequivalence limits according with the international atandars (80-125%), demonstrating that A and B formulations can be considered bioequivalent and therefore interchangeable.